Searchable abstracts of presentations at key conferences in endocrinology

ea0027p1 | (1) | BSPED2011

The vitamin D status of Irish children

Carroll Aoife , Mayne Philip , Murphy Nuala

Aim: To determine the vitamin D status among healthy Irish children.Methods: Over a 12 month period (February 2010–February 2011) well children aged 1–16 years attending for minor elective surgical procedures and medical outpatients were recruited. 25 OH vitamin D3, parathyroid hormone and bone profile were measured and a detailed questionnaire (dietary vitamin D intake, vitamin D supplements, sunlight exposure and Ethnicity) was com...

ea0027p3 | (1) | BSPED2011

Vitamin D deficiency in obese Irish children

Carroll Aoife , Mayne Philip , Murphy Nuala

Aim: To determine the vitamin D status of obese Irish children.Methods: Obese children (BMI >97th percentile) attending a weight management programme were recruited over a 12 month period (February 2010–February 2011). 25OH vitamin D3, parathyroid hormone levels and bone profile were measured. Each patient was matched to a control patient for age, sex and season.Results: Thirty-one obese children (19 female) wer...

ea0023oc5.6 | Oral Communications 5 | BSPED2009

Ongoing benefit of CSII in the improvement of HbAlc and BMI in a cohort of children with type I diabetes

Onwuneme Chike , Devenney Dympna , Corcoran Fiona , McDonnell Ciara , Murphy Nuala

Introduction: Tight metabolic control reduces the risk of microvascular complications in individuals with type 1 diabetes (T1DM). Multiple studies have shown improvements in quality of life (QOL) in children following the introduction of continuous subcutaneous insulin infusion (CSII) but metabolic outcomes have been more variable. This audit looked at metabolic parameters at long-term follow up in children and adolescents using CSII over 3 years.Methods...

ea0023p19 | (1) | BSPED2009

Congenital adrenal hyperplasia: incidence, prevalence and rationale for inclusion on the newborn screening programme in the Republic of Ireland

McDonnell Ciara , White Mary , Kelleher Suzanne , Murphy Nuala

Introduction: Congenital Adrenal Hyperplasia (CAH) carries a high risk of morbidity and mortality in undetected affected infants and has an estimated incidence of 1:15 000 based on newborn screening programmes internationally. This project aimed to identify cases and mode of diagnosis of CAH in the Republic of Ireland (ROI) to establish the case if any for screening.Methods: (i) A retrospective questionnaire was sent to all consultant paediatricians in R...

ea0023p30 | (1) | BSPED2009

Congenital hypothyroidism – A thirty year audit of the National Newborn Screening Programme in the Republic of Ireland

McDonnell Ciara , Carroll Aoife , Dockeray Sylvia , Mayne Philip , Murphy Nuala

Introduction: Congenital hypothyroidism (CHT) has a reported incidence of 1:3500 in Caucasian populations. Early detection by newborn screening and appropriate L-thyroxine treatment leads to normal or near-normal neurocognitive outcome.The National Newborn screening programme (NNP) was established in Children’s University Hospital, Temple St. in 1979. This study aimed to ascertain the incidence of congenital hypothyroidism in the Republic of Ireland...

ea0037ep1202 | Clinical Cases–Pituitary/Adrenal | ECE2015

Exaggerated cortisol response in heterozygous carriers with a mutation in the melanocortin-2 receptor (MC2R) gene

Kyithar Ma Pyeh , Green Andrew , Hughes Claire , Murphy Nuala , Byrne Maria

Introduction: Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disease characterised by ACTH resistance and isolated glucocorticoid deficiency. Mutations of ACTH receptor, known as melanocortin-2 receptor (MC2R), and melanocortin-2 receptor accessory protein (MRAP) account for approximately 25 and 15 to 20% of cases respectively. To date there is no strong evidence that heterozygous carriers have abnormal cortisol secretion.Case: We...

ea0027p44 | (1) | BSPED2011

The use of continuous s.c. insulin infusion therapy to optimize glycaemic control in children with type 1 diabetes mellitus

Carroll Aoife , Devenney Dympna , Corcoran Fiona , Shaughnessy Norma , Hayden Yvonne , Murphy Nuala

Aim: To investigate the glycaemic control of patients with T1DM before and after the introduction of CSII therapy.Methods: All patients with T1DM receiving CSII therapy for more than 6 months attending the Children’s University Hospital from 2005–2011 were included. Glycosylated haemoglobin (HbA1c) was recorded 12 and 6 months prior to starting therapy, at the time of CSII initiation and annually thereafter. Adverse events and BMI were also rec...